Arvinas Stock (NASDAQ: ARVN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 109.000 / 760.885K |
Day Range | - - - |
52 Wk Range | 13.570 - 53.080 |
Market Cap | $2.219B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 26 |
Short Interest | 12.82% |
Days to Cover | 12.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arvinas (NASDAQ: ARVN) through any online brokerage.
Other companies in Arvinas’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Arvinas (NASDAQ: ARVN) was reported by HC Wainwright & Co. on Monday, April 15, 2024. The analyst firm set a price target for 87.00 expecting ARVN to rise to within 12 months (a possible 167.77% upside). 35 analyst firms have reported ratings in the last year.
The stock price for Arvinas (NASDAQ: ARVN) is $32.49 last updated Today at April 25, 2024 at 8:30 AM EDT.
There are no upcoming dividends for Arvinas.
Arvinas’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Arvinas.
Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.